Advanced search
Publication Cover
Patient Preference and Adherence Volume 5, 2011 - Issue
Submit an article Journal homepage
557
Views
13
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

Janet A Chollet1 Beth Israel Deaconess Medical Center, Boston, MA, USA;2 Pear Tree Pharmaceuticals, Waltham, MA, USACorrespondence[email protected]
Pages 571-574 | Published online: 11 Nov 2011

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

D. J. Portman, S. R. Goldstein & R. Kagan. (2019) Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review. Climacteric 22:1, pages 65-72.
Read now
Ensieh Fooladi & Susan R Davis. (2012) An update on the pharmacological management of female sexual dysfunction. Expert Opinion on Pharmacotherapy 13:15, pages 2131-2142.
Read now

Articles from other publishers (11)

Ahmed Abdelgader, Mershen Govender, Pradeep Kumar & Yahya E. Choonara. (2023) Intravaginal Drug Delivery Systems to Treat the Genitourinary Syndrome of Menopause: Towards the Design of Safe and Efficacious Estrogen-loaded Prototypes. Journal of Pharmaceutical Sciences 112:6, pages 1566-1585.
Crossref
Ismin Zainol Abidin, Emma Murphy, Gustavo Waltzer Fehrenbach, Emanuele Rezoagli, Noel Gately & Ian Major. (2023) A systematic review of mucoadhesive vaginal tablet testing. Drug Target Insights 17, pages 5-30.
Crossref
Emory S. Buck, Vanessa A. Lukas & Rachel S. Rubin. (2021) Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause. Urology 151, pages 31-36.
Crossref
Tamara A. Sussman, Megan L. Kruse, Holly L. Thacker & Jame Abraham. (2019) Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy. Journal of Oncology Practice 15:7, pages 363-370.
Crossref
Melissa J Buttini & Christopher Maher. (2018) The first published randomised controlled trial of laser treatment for vaginal atrophy raises serious questions. Medical Journal of Australia 209:9, pages 376-377.
Crossref
Carolyn M. Klinge, Barbara J. Clark & Russell A. Prough. 2018. Dehydroepiandrosterone. Dehydroepiandrosterone 1 28 .
Eleni Pitsouni, Themos Grigoriadis, Matthew Falagas, Angeliki Tsiveleka, Stefano Salvatore & Stavros Athanasiou. (2017) Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?. Lasers in Medical Science 32:8, pages 1865-1872.
Crossref
M. A. Weber, J. Limpens & J. P. W. R. Roovers. (2014) Assessment of vaginal atrophy: a review. International Urogynecology Journal 26:1, pages 15-28.
Crossref
Christine Bradway & Joseph Boullata. (2014) Pharmacologic therapy for female sexual dysfunction. The Nurse Practitioner 39:1, pages 16-27.
Crossref
Savita Singh, Ineke van Herwijnen & Christian Phillips. (2013) The management of lower urogenital changes in the menopause. Menopause International 19:2, pages 77-81.
Crossref
Ning-xia SUN, Zhi-jun JIN, Xiao-feng JIA & Wen LI. (2012) Black cohosh improves vaginal atrophy in postmenopausal women. Academic Journal of Second Military Medical University 32:3, pages 339-341.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.